Henan Lingrui Pharmaceutical Co Ltd (600285) — Cash Flow Quality Index
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Cash Flow Quality Index of 0.79x as of September 2025. Operating cash flow of CN¥140.12 Million is below net income of CN¥176.55 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 600285 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Henan Lingrui Pharmaceutical Co Ltd Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Henan Lingrui Pharmaceutical Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Henan Lingrui Pharmaceutical Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Year-by-year earnings quality comparison for Henan Lingrui Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Henan Lingrui Pharmaceutical Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.73x | CN¥553.88 Million | CN¥759.50 Million | ▼ -39.8% |
| 2024 | 1.21x | CN¥875.86 Million | CN¥722.58 Million | ▼ -15.3% |
| 2023 | 1.43x | CN¥813.43 Million | CN¥568.11 Million | ▼ -20.2% |
| 2022 | 1.79x | CN¥834.91 Million | CN¥465.33 Million | ▼ -23.1% |
| 2021 | 2.33x | CN¥845.69 Million | CN¥362.50 Million | ▲ +68.0% |
| 2020 | 1.39x | CN¥450.53 Million | CN¥324.38 Million | ▼ -9.6% |
| 2019 | 1.54x | CN¥450.15 Million | CN¥293.15 Million | ▼ -13.5% |
| 2018 | 1.78x | CN¥436.25 Million | CN¥245.77 Million | ▲ +276.8% |
| 2017 | 0.47x | CN¥105.97 Million | CN¥224.93 Million | ▲ +159.0% |
| 2016 | 0.18x | CN¥63.26 Million | CN¥347.72 Million | ▼ -84.5% |
| 2015 | 1.17x | CN¥156.82 Million | CN¥133.71 Million | ▼ -28.1% |
| 2014 | 1.63x | CN¥124.32 Million | CN¥76.22 Million | ▲ +35.1% |
| 2013 | 1.21x | CN¥127.27 Million | CN¥105.39 Million | ▲ +226.7% |
| 2012 | 0.37x | CN¥15.43 Million | CN¥41.76 Million | ▼ -72.9% |
| 2011 | 1.36x | CN¥40.49 Million | CN¥29.67 Million | ▲ +1769.3% |
| 2010 | -0.08x | CN¥-3.95 Million | CN¥48.34 Million | ▼ -101.8% |
| 2009 | 4.49x | CN¥132.61 Million | CN¥29.51 Million | ▲ +13.5% |
| 2008 | 3.96x | CN¥43.72 Million | CN¥11.04 Million | ▲ +1684.4% |
| 2007 | 0.22x | CN¥15.99 Million | CN¥72.03 Million | ▼ -91.0% |
| 2006 | 2.48x | CN¥26.76 Million | CN¥10.80 Million | ▲ +35.2% |
| 2005 | 1.83x | CN¥33.43 Million | CN¥18.23 Million | ▼ -27.7% |
| 2004 | 2.54x | CN¥35.51 Million | CN¥13.99 Million | ▲ +42.7% |
| 2003 | 1.78x | CN¥23.79 Million | CN¥13.38 Million | ▼ -66.8% |
| 2002 | 5.36x | CN¥69.41 Million | CN¥12.96 Million | ▲ +3843.4% |
| 2001 | 0.14x | CN¥3.41 Million | CN¥25.11 Million | ▲ +1.6% |
| 2000 | 0.13x | CN¥3.66 Million | CN¥27.40 Million | ▼ -69.3% |
| 1999 | 0.43x | CN¥4.81 Million | CN¥11.06 Million | — |